Comparing ASHC and CDSMP Outcomes In Arthritis

This study has been completed.
Sponsor:
Collaborators:
University of North Carolina, Chapel Hill
East Carolina University
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00207441
First received: September 13, 2005
Last updated: March 23, 2011
Last verified: March 2011
  Purpose

The arthritis-specific Arthritis Self Help Course (ASHC) and the more generic Chronic Disease Self Management Program (CDSMP) teach generalizable skills for managing arthritis and other chronic diseases. In some locations it may be more feasible to combine efforts and offer the generic course rather than the arthritis-specific program. However anecdotal evidence has questioned whether people with arthritis obtain as much benefit from the more generic course as they do the arthritis-specific course. The primary purpose of this research studies is to compare health outcomes among people with arthritis who participate in either ASHC or the CDSMP. The North Carolina project is focusing primarily on African Americans from 6 rural counties in North Carolina. The results of this research will be used to guide Arthritis program recommendations on the use of ASHC and CDSMP to improve the quality of life for people with arthritis.


Condition Intervention
Arthritis
Behavioral: Arthritis Self management program
Behavioral: Chronic Disease Self Management Program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Comparing ASHC and CDSMP Outcomes In Arthritis

Resource links provided by NLM:


Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Health related quality of life, measured at 4 and 12 months, [ Time Frame: 4 months, 12 months ] [ Designated as safety issue: No ]
  • Health care utilization measured at 4 and 12 months [ Time Frame: 4 months, 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Self management behaviors measured at 4 and 12 months [ Time Frame: 4 months, 12 months ] [ Designated as safety issue: No ]
  • Self efficacy for arthritis management, measured at 4 and 12 months [ Time Frame: 4 months, 12 months ] [ Designated as safety issue: No ]

Enrollment: 416
Study Start Date: April 2003
Study Completion Date: August 2006
Primary Completion Date: October 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arthritis self management program Behavioral: Arthritis Self management program
Other Names:
  • ASHC
  • AFSMP
Experimental: Chronic Disease Self Management Program Behavioral: Chronic Disease Self Management Program
Other Names:
  • Living Well with Chronic Conditions
  • Healthy Living

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

African american adults with arthritis Caucasian adults with arthritis

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00207441

Locations
United States, North Carolina
Craven County Health Department
New Bern, North Carolina, United States, 28561
Sponsors and Collaborators
University of North Carolina, Chapel Hill
East Carolina University
Investigators
Principal Investigator: Jean Goeppinger, PhD RN University of North Carolina, Chapel Hill
  More Information

No publications provided

Responsible Party: Jean Goeppinger, PhD, RN, FAAN, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT00207441     History of Changes
Other Study ID Numbers: CDC-NCCDPHP-S2233-22/33, S2233-22/23
Study First Received: September 13, 2005
Last Updated: March 23, 2011
Health Authority: United States: Federal Government

Keywords provided by Centers for Disease Control and Prevention:
arthritis
chronic disease
self management
self efficacy

Additional relevant MeSH terms:
Arthritis
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on April 17, 2014